DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$203.06

Market cap

$22.48B

P/E Ratio

22.14

Dividend/share

$3.26

EPS

$9.17

Enterprise value

$28.49B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 67
Relative Profitability: Rel. Profitability: 68

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
The net income has grown by 14% YoY and by 3.2% from the previous quarter
DGX's EPS is up by 14% year-on-year and by 3.4% since the previous quarter
Quest Diagnostics's quick ratio has decreased by 17% YoY but it has increased by 14% QoQ
DGX's price to earnings (P/E) is 32% higher than its 5-year quarterly average of 16.8 and 4.9% higher than its last 4 quarters average of 21.1
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.questdiagnostics.com/
Peers: LH NEO QGEN

Key stats

What are the main financial stats of DGX

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
-0.38%
1 week
1.38%
1 month
6.77%
1 year
13.42%
YTD
17.02%
QTD
3.61%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$11.28B
Gross profit
$3.74B
Operating income
$1.61B
Net income
$1.02B
Gross margin
33.2%
Net margin
9.1%
DGX's operating income is up by 16% year-on-year and by 3.4% since the previous quarter
The net income has grown by 14% YoY and by 3.2% from the previous quarter
The gross profit has increased by 12% YoY and by 2.2% from the previous quarter
The revenue has grown by 11% YoY and by 2.2% from the previous quarter

Price vs fundamentals

How does DGX's price correlate with its fundamentals

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
DGX P/E details
P/E
22.14
P/B
3.03
P/S
1.98
EV/EBIT
17.66
EV/EBITDA
13.01
EV/Sales
2.53
DGX's price to earnings (P/E) is 32% higher than its 5-year quarterly average of 16.8 and 4.9% higher than its last 4 quarters average of 21.1
DGX's EPS is up by 14% year-on-year and by 3.4% since the previous quarter
The stock's price to book (P/B) is 17% more than its 5-year quarterly average of 2.6 and 8% more than its last 4 quarters average of 2.8
Quest Diagnostics's equity has increased by 6% YoY and by 2.7% from the previous quarter
The stock's price to sales (P/S) is 16% more than its 5-year quarterly average of 1.7 and 4.2% more than its last 4 quarters average of 1.9
The revenue has grown by 11% YoY and by 2.2% from the previous quarter

Efficiency

How efficient is Quest Diagnostics business performance
Quest Diagnostics's return on invested capital has increased by 15% YoY and by 3.7% QoQ
DGX's return on assets is up by 9% year-on-year
DGX's ROE is up by 7% year-on-year
DGX's return on sales is up by 4.4% year-on-year

Dividends

What is DGX's dividend history
Dividend details
DPS
$3.26
Dividend yield
1.61%
Payout ratio
35.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 85% greater than the total liabilities
The current ratio has decreased by 18% YoY but it has increased by 13% QoQ
Quest Diagnostics's quick ratio has decreased by 17% YoY but it has increased by 14% QoQ
Quest Diagnostics's debt is 13% lower than its equity
The company's debt to equity fell by 8% YoY and by 2.2% QoQ
Quest Diagnostics's equity has increased by 6% YoY and by 2.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.